Botanical species · safety record

Lepidium draba

The EFSA Compendium of Botanicals holds 10 constituent measurements for Lepidium draba. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lepidium draba L.

10Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Also recorded as

Cardaria draba (L.) Desv.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Live plants	Solvent extraction	—	Phytochemical screening	No resolvable identifier
Erucic acid	Leaves	Solvent extraction	1.23 Percent	Gaschromatography (GC)	No resolvable identifier
Glucoraphanin	Leaves	Solvent extraction	30 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	81 Microgram/gram	GC-MS	No resolvable identifier
Glucosinolates	Flowering top	—	—	Colorimetry, Spectroscopy (Spectrometry) and Photometry	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	69 Microgram/gram	GC-MS	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	306 Microgram/gram	GC-MS	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	618 Microgram/gram	GC-MS	No resolvable identifier
Glucosinolates	Seed	Solvent extraction	13 Microgram/gram	GC-MS	No resolvable identifier
Oxalic acid	Leaves	Solvent extraction	—	Gaschromatography (GC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Hasapis, Xenophon., MacLeod, Alexander J., Moreau, Marie. Glucosinolates of nine Cruciferae and two Capparaceae species. Phytochemistry (Elsevier), 1981, p. 2355-2358.
Frechard, Antoine., Fabre, Nicolas., Hannedouche, Sebastien., Fouraste, Isabelle. Glucosinolates from Cardaria draba. Fitoterapia, 2002, p. 177-178.
Guil, J. L., Rodriguez-Garcia, I., Torija, E. Nutritional and toxic factors in selected wild edible plants. Plant foods for human nutrition (dordrecht, netherlands), 1997, p. 99-107.
Powell, Erin E., Hill, Gordon A., Juurlink, Bernhard H. J., Carrier, D. Julie. Glucoraphanin extraction from Cardaria draba: Part 1. Optimization of batch extraction. Journal of Chemical Technology and Biotechnology, 2005, p. 985-991.
Potapov, V. M. Phytochemical study of Cardaria draba. Meditsinskii zhurnal uzbekistana, 1976, p. 61-62.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature